These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24658707)

  • 1. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
    Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
    Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients.
    Tigchelaar I; Gallandat Huet RC; Boonstra PW; van Oeveren W
    Perfusion; 1998 Sep; 13(5):297-303. PubMed ID: 9778712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
    Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study.
    Golab HD; Scohy TV; de Jong PL; Kissler J; Takkenberg JJ; Bogers AJ
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):886-91. PubMed ID: 21055963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-induced fluid extravasation during cardiopulmonary bypass in piglets can be counteracted by use of iso-oncotic prime.
    Farstad M; Kvalheim VL; Husby P
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):287-94. PubMed ID: 16077389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
    Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL
    Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary study of colloid osmotic pressure for cardiopulmonary bypass].
    Wang D; Xiang L; Luo J
    Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):751-3. PubMed ID: 9590779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High colloid oncotic pressure priming of cardiopulmonary bypass in neonates and infants: implications on haemofiltration, weight gain and renal function.
    Loeffelbein F; Zirell U; Benk C; Schlensak C; Dittrich S
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):648-52. PubMed ID: 18667327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
    Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
    Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
    Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
    Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
    Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
    J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
    Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
    Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.
    Gallandat Huet RC; Siemons AW; Baus D; van Rooyen-Butijn WT; Haagenaars JA; van Oeveren W; Bepperling F
    Can J Anaesth; 2000 Dec; 47(12):1207-15. PubMed ID: 11132743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?
    Boks RH; Wijers MJ; Hofland J; Takkenberg JJ; Bogers AJ
    Perfusion; 2007 Sep; 22(5):333-7. PubMed ID: 18416219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions.
    Saunders CR; Carlisle L; Bick RL
    Ann Thorac Surg; 1983 Nov; 36(5):532-9. PubMed ID: 6195981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
    London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normovolemic hemodilution using hydroxyethyl starch 130/0.4 (Voluven) in a Jehovah's Witness child requiring cardiopulmonary bypass for ventricular septal defect repair.
    Laliberte BD; Nath DS; Costello JP; Nuszkowski M; Kaplan RF
    J Clin Anesth; 2014 Aug; 26(5):402-6. PubMed ID: 25123329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin utilization in cardiac surgery after transition to hydroxyethyl starch 130/0.4.
    Romerill DB; Toyoda AY; Brodeur BE; Moellentin D
    J Pharm Pract; 2012 Dec; 25(6):606-10. PubMed ID: 22797837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.